To access this element change to forms mode OFF
Grant Award View - GA276519
New approaches to treating hemoglobinopathies
GA ID:
GA276519
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Oct-2022
Publish Date:
19-Dec-2022
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2027
Value (AUD):
$1,508,780.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
New approaches to treating hemoglobinopathies
Purpose:
The genetic disorders β-thalassemia and sickle cell disease are caused by mutations in the adult globin gene. Fortunately, humans have a second globin gene, the fetal globin gene, which is expressed in utero but turned off after birth. Re-activating expression of this fetal globin gene can alleviate the symptoms of β-thalassemia and sickle cell disease. We are using new strategies, including sophisticated gene editing, to boost fetal globin output to treat this disease.
GO ID:
GO Title:
Ideas Grants 2022
Internal Reference ID:
2022/GNT2020861
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Kensington
Town/City:
Kensington
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW
Postcode:
Multiple
Country:
AUSTRALIA